MH–109 was conducted at HIPAA-compliant centers in the US and in Europe
according to Good Clinical Practice standards. Participating centers were:

Neuroradiology and MR Research Laboratory
University of Washington
Seattle, WA

Department of Radiology
Wake Forest University School of Medicine
Winston-Salem, NC

Neuroradiology Research
University of Florida
Gainsville, FL

Department of Radiology
Southern Illinois University School of Medicine
Springfield, IL

Department of Radiology
University of Miami School of Medicine
Miami, FL

Department of Radiology
Washington University
St. Louis, MO

Department of Radiology
Scott and White Memorial Hospital
Temple, TX

Department of Radiology
The Ohio State University — University Hospitals
Columbus, OH

Department Neuroradiology
Centre Hospitalier et Universitaire de Neuroradiologie
Nancy, France

Department of Radiology
University Hospital
Newark, NJ

Department of Neuroradiology
S Raffaele Hospital
Milan, Italy

German Cancer Research Institute
Heidelberg, Germany

Department of Neuroradiology
Sahlgrenska University Hospital
Sweden

© 2008 Bracco Diagnostics Inc.